Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > The Panc cancer results are very good!
View:
Post by canadafan on May 20, 2021 10:09am

The Panc cancer results are very good!

The Panc cancer results are very good.
Panc cancer is almost untreatable. They showed moderate efficacy....that is great.
add that on- top- of , most recent Car-t results " complete cure" and Mbc & a bio marker 
they have good reason to be somewhat arrogant, with the future.
enough $ to last 1.5 yrs & about 3 major announcements within next 6 months.
The Car-t partnership will be early ( my prediction) this fall.
moving SP into a reasonable range, to negotiate the phase 3 deal.
lots of irons in the fire & the SP does not come even close to reflecting that.
Comment by Actuarial on May 20, 2021 10:23am
Not sure if "modest" = very good or not. I kind of suspect this management team be dishonest, i.e., cherry picking to release the results. "The combination of pelareorep and pembrolizumab showed a manageable safety profile and modest efficacy in an unselected PDAC population. Additional correlation analyses between treatment efficacy and immunological changes will be presented. The ...more  
Comment by JohnnyYeg on May 20, 2021 11:49am
Are you serious Actuarial??? "don't know if modest efficacy is good"?? For a death sentence like pancreatic cancer, honestly tell me modest efficacy isn't good. SMH.
Comment by Actuarial on May 20, 2021 11:52am
modest DEFINITIONS AND SYNONYMS ‌‌ ADJECTIVE UK/mdst/ DEFINITIONS3 1 fairly small, especially when compared with other things of the same type The engine has a very modest oil consumption.  ...more  
Comment by Actuarial on May 20, 2021 12:22pm
Don't forget. pembrolizumab alone also play an important role in the treatment. That's why it is called modest rather than "very promising".
Comment by fox7mf on May 20, 2021 11:33am
As per usual, another great post canadafan. Onc smacks of confidence, and a partnership(s) or a complete buyout is coming before the end of the year. IMO.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities